Anti-CD321 antibody immunotherapy protects liver against ischemia and reperfusion-induced injury

[1]  H. Nakano,et al.  Inhibition of Importin β1 Augments the Anticancer Effect of Agonistic Anti-Death Receptor 5 Antibody in TRAIL-resistant Tumor Cells , 2020, Molecular Cancer Therapeutics.

[2]  J. Pawlotsky,et al.  Small-molecule inhibitors of cyclophilins block opening of the mitochondrial permeability transition pore and protect mice from hepatic ischemia-reperfusion injury. , 2019, Gastroenterology.

[3]  Iain Dickson.  Improving hepatic ischaemia–reperfusion injury outcomes , 2019, Nature Reviews Gastroenterology & Hepatology.

[4]  A. Takamori,et al.  The phytosphingosine-CD300b interaction promotes zymosan-induced, nitric oxide–dependent neutrophil recruitment , 2019, Science Signaling.

[5]  O. Soehnlein,et al.  Organ-Specific Mechanisms of Transendothelial Neutrophil Migration in the Lung, Liver, Kidney, and Aorta , 2018, Front. Immunol..

[6]  P. Clavien,et al.  Exogenous melatonin protects small‐for‐size liver grafts by promoting monocyte infiltration and releases interleukin‐6 , 2018, Journal of pineal research.

[7]  M. Uchiyama,et al.  Graft protective effect and induction of CD4+Foxp3+ cell by Thrombomodulin on allograft arteriosclerosis in mice , 2018, Journal of Cardiothoracic Surgery.

[8]  Hongliang Li,et al.  An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury , 2017, Nature Medicine.

[9]  N. Hattori,et al.  A novel immunotoxin reveals a new role for CD321 in endothelial cells , 2017, PloS one.

[10]  Jie-Young Song,et al.  Fate of Neutrophils during the Recovery Phase of Ischemia/Reperfusion Induced Acute Kidney Injury , 2017, Journal of Korean medical science.

[11]  F. Wang,et al.  Cholecystokinin protects mouse liver against ischemia and reperfusion injury , 2017, International immunopharmacology.

[12]  V. Fuster,et al.  Neutrophil stunning by metoprolol reduces infarct size , 2017, Nature Communications.

[13]  Haoming Zhou,et al.  Innate Immune Regulations and Liver Ischemia-Reperfusion Injury. , 2016, Transplantation.

[14]  J. Pfeilschifter,et al.  Murine junctional adhesion molecules JAM-B and JAM-C mediate endothelial and stellate cell interactions during hepatic fibrosis , 2016, Cell adhesion & migration.

[15]  X. Forns,et al.  Therapy: Statins and liver disease: from concern to 'wonder' drugs? , 2015, Nature Reviews Gastroenterology &Hepatology.

[16]  I. Komuro,et al.  Anti‐Inflammatory Peptides From Cardiac Progenitors Ameliorate Dysfunction After Myocardial Infarction , 2014, Journal of the American Heart Association.

[17]  M. Servant,et al.  TNF‐α expression in neutrophils and its regulation by glycogen synthase kinase‐3: A potentiating role for lithium , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  B. Imhof,et al.  Tight junction dynamics: the role of junctional adhesion molecules (JAMs) , 2014, Cell and Tissue Research.

[19]  Johnny C. Hong,et al.  Ischaemia–reperfusion injury in liver transplantation—from bench to bedside , 2013, Nature Reviews Gastroenterology &Hepatology.

[20]  Eric C. Sorenson,et al.  Nilotinib protects the murine liver from ischemia/reperfusion injury. , 2012, Journal of hepatology.

[21]  R. Keep,et al.  Relocalization of Junctional Adhesion Molecule A during Inflammatory Stimulation of Brain Endothelial Cells , 2012, Molecular and Cellular Biology.

[22]  Baptiste N. Jaeger,et al.  Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis , 2012, The Journal of experimental medicine.

[23]  T. Eckle,et al.  Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.

[24]  Y. Zhai,et al.  Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate—Adaptive Immune‐Mediated Tissue Inflammation , 2011, American Journal of Transplantation.

[25]  P. Meda,et al.  Junctional adhesion molecule-C (JAM-C) regulates polarized neutrophil transendothelial cell migration in vivo , 2011, Nature immunology.

[26]  P. Meda,et al.  Junctional adhesion molecule-C (JAM-C) regulates polarized neutrophil transendothelial cell migration in vivo , 2011, Nature Immunology.

[27]  D. Belsham,et al.  Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[29]  E. Dejana,et al.  The role of junctional adhesion molecules in vascular inflammation , 2007, Nature Reviews Immunology.

[30]  E. Dejana,et al.  The role of JAM‐A and PECAM‐1 in modulating leukocyte infiltration in inflamed and ischemic tissues , 2006, Journal of leukocyte biology.

[31]  David A. Brenner,et al.  Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways , 2006 .

[32]  M. Corada,et al.  Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Corada,et al.  Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. , 2005, Blood.

[34]  H. Jaeschke,et al.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. , 2003, Gastroenterology.

[35]  A. Zernecke,et al.  JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes , 2002, Nature Immunology.

[36]  K. Frei,et al.  Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection. , 2000, The Journal of infectious diseases.

[37]  K. McMasters,et al.  Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury , 2000, Hepatology.

[38]  E. Dejana,et al.  Leukocyte Recruitment in the Cerebrospinal Fluid of Mice with Experimental Meningitis Is Inhibited by an Antibody to Junctional Adhesion Molecule (Jam) , 1999, The Journal of experimental medicine.

[39]  E. Dejana,et al.  Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.

[40]  L. Toledo-Pereyra,et al.  NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY , 1993, Transplantation.

[41]  H. Jaeschke,et al.  Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. , 1991, The American journal of physiology.

[42]  R. Strieter,et al.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.

[43]  P. Proost,et al.  Neutrophils: a cornerstone of liver ischemia and reperfusion injury , 2018, Laboratory Investigation.

[44]  Hongliang Li,et al.  Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression. , 2017, Journal of hepatology.

[45]  Lu Gao,et al.  Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury. , 2016, Journal of hepatology.

[46]  Y. Abe,et al.  Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. , 2009, Free radical biology & medicine.

[47]  R. Schwabe,et al.  Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[48]  M. Smyth,et al.  Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection , 2002, Nature Immunology.

[49]  M. Smyth,et al.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells , 2001, Nature Medicine.